84 related articles for article (PubMed ID: 25669749)
1. Consistent nuclear expression of thyroid transcription factor 1 in subependymal giant cell astrocytomas suggests lineage-restricted histogenesis.
Hewer E; Vajtai I
Clin Neuropathol; 2015; 34(3):128-31. PubMed ID: 25669749
[TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.
Hang JF; Hsu CY; Lin SC; Wu CC; Lee HJ; Ho DM
Mod Pathol; 2017 Mar; 30(3):318-328. PubMed ID: 27910945
[TBL] [Abstract][Full Text] [Related]
3. Subependymal giant cell astrocytoma (SEGA): Is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study.
Buccoliero AM; Franchi A; Castiglione F; Gheri CF; Mussa F; Giordano F; Genitori L; Taddei GL
Neuropathology; 2009 Feb; 29(1):25-30. PubMed ID: 18564101
[TBL] [Abstract][Full Text] [Related]
4. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
Gyure KA; Prayson RA
Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
[TBL] [Abstract][Full Text] [Related]
5. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.
Buccoliero AM; Caporalini C; Giordano F; Mussa F; Scagnet M; Moscardi S; Baroni G; Genitori L; Taddei GL
Clin Neuropathol; 2016; 35(5):295-301. PubMed ID: 27390104
[TBL] [Abstract][Full Text] [Related]
6. Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile.
Giannikou K; Zhu Z; Kim J; Winden KD; Tyburczy ME; Marron D; Parker JS; Hebert Z; Bongaarts A; Taing L; Long HW; Pisano WV; Alexandrescu S; Godlewski B; Nellist M; Kotulska K; Jozwiak S; Roszkowski M; Mandera M; Thiele EA; Lidov H; Getz G; Devinsky O; Lawrence MS; Ligon KL; Ellison DW; Sahin M; Aronica E; Meredith DM; Kwiatkowski DJ
Mod Pathol; 2021 Feb; 34(2):264-279. PubMed ID: 33051600
[TBL] [Abstract][Full Text] [Related]
7. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.
Ess KC; Kamp CA; Tu BP; Gutmann DH
Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742
[TBL] [Abstract][Full Text] [Related]
8. TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.
Dutta R; Sharma MC; Suri V; Sarkar C; Garg A; Suri A; Kale SS
World Neurosurg; 2022 Mar; 159():e62-e69. PubMed ID: 34871801
[TBL] [Abstract][Full Text] [Related]
9. Subependymal giant cell astrocytoma--a clinicopathological study of 23 cases with special emphasis on histogenesis.
Sharma MC; Ralte AM; Gaekwad S; Santosh V; Shankar SK; Sarkar C
Pathol Oncol Res; 2004; 10(4):219-24. PubMed ID: 15619643
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
11. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus.
Katz JS; Milla SS; Wiggins GC; Devinsky O; Weiner HL; Roth J
J Neurosurg Pediatr; 2012 Apr; 9(4):406-13. PubMed ID: 22462706
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
You H; Kim YI; Im SY; Suh-Kim H; Paek SH; Park SH; Kim DG; Jung HW
J Neurooncol; 2005 Aug; 74(1):1-8. PubMed ID: 16078101
[TBL] [Abstract][Full Text] [Related]
14. [Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; Carceller F; Hernández-Moneo JL; Gutiérrez-Molina M; Morales C
Neurologia; 2010 Jun; 25(5):314-21. PubMed ID: 20643042
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma: case report.
Rodgers SD; Bassani L; Weiner HL; Harter DH
J Neurosurg Pediatr; 2012 Apr; 9(4):417-20. PubMed ID: 22462708
[TBL] [Abstract][Full Text] [Related]
16. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of subependymal giant cell astrocytomas.
Lopes MB; Altermatt HJ; Scheithauer BW; Shepherd CW; VandenBerg SR
Acta Neuropathol; 1996; 91(4):368-75. PubMed ID: 8928613
[TBL] [Abstract][Full Text] [Related]
18. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
[TBL] [Abstract][Full Text] [Related]
19. Solitary subependymal giant cell astrocytoma incidentally found at autopsy in an elderly woman without tuberous sclerosis complex.
Takei H; Adesina AM; Powell SZ
Neuropathology; 2009 Apr; 29(2):181-6. PubMed ID: 18673443
[TBL] [Abstract][Full Text] [Related]
20. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.
Shepherd CW; Scheithauer BW; Gomez MR; Altermatt HJ; Katzmann JA
Neurosurgery; 1991 Jun; 28(6):864-8. PubMed ID: 2067610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
